HHMI
ZBH icon

Howard Hughes Medical Institute’s Zimmer Biomet ZBH Stock Holding History

Howard Hughes Medical Institute’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43
Closed -$3.87K – 491
2025
Q4 		$3.87K Hold
43
– – ﹤0.01% 392
2025
Q3 		$4.24K Hold
43
– – ﹤0.01% 373
2025
Q2 		$3.92K Buy
+43
New +$4.16K ﹤0.01% 378
2014
Q4 		– Sell
-472
Closed -$46K – 195
2014
Q3 		$46K Buy
+472
New +$46.4K 0.01% 161

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Howard Hughes Medical Institute's ZBH Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 43 shares — an estimated $3.87K sold.

Howard Hughes Medical Institute first reported a position in ZBH in Q3 2014 and held it in 4 quarters. The position peaked at $46K in Q3 2014. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 43 Zimmer Biomet shares in Q1 2026, an estimated $3.87K.
  • Howard Hughes Medical Institute first reported a position in Zimmer Biomet in Q3 2014 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Zimmer Biomet position peaked at $46K in Q3 2014.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.